S uppressive myeloid cells were first described in tumor models accompanied by a strong leukemoid reaction 1 . Based on surface markers in mice and humans, mononuclear (monocytic) myeloid-derived suppressor cells (M-MDSCs) and polymorphonuclear (granulocytic) MDSCs (PMN-MDSCs) have been described 2 . The surface lectin-type receptor LOX1, encoded by the OLR1 gene, is specifically expressed on PMN-MDSCs in humans 3 . In mice, PMN-MDSCs are characterized as CD11b + Ly6G + Ly6C int cells, which are also markers for bona fide neutrophils. However, because PMN-MDSCs are considered aberrantly activated neutrophils, the imprinting of distinct signaling pathways in CD11b + Ly6G + Ly6C int cells can be used to detect MDSCs in tissues of mice and humans. For instance, PMN-MDSCs respond to signals transduced by the transcription factor STAT3 for expansion and survival in situ, and robust activation of STAT3 is a hallmark of PMN-MDSCs and secures their functional phenotype 4 . PMN-MDSCs strongly suppress CD8 + T cell responses against tumor cells. Less is known about the role of PMN-MDSCs in autoimmunity. PMN-MDSCs interact with B cells to inhibit the proliferation and differentiation of B cells in vitro 5 and in vivo 6 , or to induce regulatory B cells 7 or IgA + antibody-secreting cells 8 . PMN-MDSCs also prevent the expansion of CD19 + CD138 + B cells in an indirect manner by suppressing T follicular helper cell functions 9 .
B cells serve as precursors of antibody-secreting cells and provide cytokines, in particular interleukin-6 (IL-6), to promote germinal center reactions. B cells also present their cognate antigens to T cells and give T cells help. Compelling data supporting all of these functions have been reported in the context of central nervous system (CNS) autoimmunity in preclinical models 10, 11 . Circumstantial evidence from clinical trials suggests that B cell-depleting therapies in MS might mainly affect the antigen-presenting function of B cells 12 . Notably, B cells that repopulate after B cell depletion tend to produce IL-10 instead of GM-CSF and contribute to sustained tolerance 13 . Thus, in addition to their function as antigen-presenting cells, B cells might also exert a damaging function due to the secretion of cytokines. Finally, there is an ongoing debate about the structure and function of aggregates of B cells in the subarachnoid space. In particular, the initiation and severity of the chronic disease phase in MS is associated with the accumulation of these B cell aggregates 14 . Therefore, B cells seem to facilitate a compartmentalized inflammatory process in the CNS that is disconnected from the systemic immune system.
Here, we sought to investigate the autoregulatory loops that control the recruitment, maintenance and function of B cells in the cerebrospinal fluid (CSF) and CNS parenchyma. Foxp3 + regulatory T cells (T reg cells) directly regulate some functions of B cells [15] [16] [17] . However, in experimental autoimmune encephalomyelitis (EAE), depletion of T reg cells leads to an exacerbated disease course that
Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity
Ly6G + cells persist in CSF of mice during recovery from EAE. To test the function of PMN-MDSCs in autoimmune neuroinflammation, we induced EAE in mice by immunization with myelin oligodendrocyte glycoprotein (MOG) peptide in complete Freund's adjuvant (CFA); this treatment reflects many immunemediated aspects of human MS 21 . We used Ly6G-tdTomato reporter mice, in which Ly6G + cells can be tracked by expression of tdTomato (hereafter called Ly6g Cre/WT ) 22 , and analyzed Ly6G-tdTomato + cells in the CNS, CSF and blood during EAE. We observed an increase in the fraction of Ly6G-tdTomato + cells at disease onset (days 10-12) and a persisting population of Ly6G-tdTomato + cells during the recovery phase (days [20] [21] [22] in the CSF compared to blood ( Fig. 2a,b ), concomitant with a second 'peak' of protein expression of the chemokine CXCL1 in the CSF (Fig. 2c) . Phenotypically, the 'monocytic' appearance of Ly6G-tdTomato + cells during the recovery phase was reminiscent of PMN-MDSCs, but very different from that of Ly6G-tdTomato + cells collected from the peripheral immune compartment, which had segmented nuclei (Fig. 2d ). Inducible nitric oxide synthase (iNOS) was highly expressed and arginase activity strongly increased in Ly6G-tdTomato + cells isolated from the CNS at recovery as compared to onset ( Fig. 2e,f) . Taken together, these data suggest that the Ly6G-tdTomato + cells in the CNS during the recovery phase were phenotypically similar to PMN-MDSCs.
Ly6G + cells acquire an MDSC-like transcriptome in the CNS.
To obtain a more comprehensive understanding of PMN-MDSCs during CNS autoimmunity, we performed RNA sequencing (RNAseq) analysis on Ly6G-tdTomato + cells sorted from the spleen and CNS of Ly6g Cre/WT mice at onset (day 12) and during the recovery phase (day 22) of EAE. Principal component analysis segregated CNS-derived Ly6G-tdTomato + cells from spleen-derived Ly6G-tdTomato + cells (Fig. 3a) . In particular, the transcriptome of CNSderived Ly6G-tdTomato + cells at disease onset seemed most distinct from all other subsets according to principal component 1 (PC1), and two MDSC hallmark genes, Nos2 and Arg1, were significantly upregulated in CNS-onset, but not CNS-recovery Ly6G-tdTomato + cells compared to their expression in spleen Ly6G-tdTomato + cells ( Supplementary Fig. 2 ). Because Nos2 and Arg1 proteins were highly upregulated in CNS-recovery Ly6G-tdTomato + cells compared to CNS-onset Ly6G-tdTomato + cells ( Fig. 2e,f) , these data suggest that the transcriptome of CNS-onset Ly6G-tdTomato + cells reflects the functional phenotype of CNS-recovery Ly6G-tdTomato + cells, consistent with the delay imparted by RNA translation into protein. Moreover, in gene set enrichment analyses, a set of known human MDSC signature genes (such as PRDX1, OLR1, IRF8 and DOCK10) 3 was enriched in samples with high PC1 and PC3 ranks ( Fig. 3b and Supplementary Fig. 2 ), indicating that the transcriptome of CNS-onset Ly6G-tdTomato + cells was the most similar to a PMN-MDSC profile.
To further analyze the transcriptome of CNS-onset Ly6G-tdTomato + cells, we identified 484 genes that were universally downregulated and 1,110 genes that were universally upregulated in CNS-onset Ly6G-tdTomato + cells as compared to all other Ly6G-tdTomato + cell subsets, respectively ( Supplementary Table  1 ). Among the genes that were differentially downregulated in CNS-onset Ly6G-tdTomato + cells, gene ontology terms including oxidoreductase activity, coenzyme binding and histone kinase activity were significantly overrepresented, whereas cytokine receptor binding, amide binding and enzyme inhibitor activity were significantly enriched in the set of genes universally upregulated in CNS-onset Ly6G-tdTomato + cells ( Fig. 3c , Supplementary Fig. 2 and Supplementary Tables 2 and 3) . Notably, the mRNA for Olr1, the mouse homolog of human OLR1 (which encodes LOX1), was significantly upregulated in CNS-onset Ly6G-tdTomato + cells compared to all other Ly6G-tdTomato + populations ( Supplementary  Table 1 ). In summary, the PMN-MDSC signature was restricted to CNS Ly6G-tdTomato + cells, whereas splenic Ly6G-tdTomato + cells did not show an MDSC-like profile.
To test whether Ly6G + cells acquired the MDSC profile in the inflamed CNS compartment, we transferred Ly6G-tdTomato + cells isolated from the spleen of MOG(35-55) plus CFA-immunized CD45.2 + Ly6g Cre/WT mice into MOG(35-55) plus CFA-immunized congenic CD45.1 + host mice two days after onset of clinical signs Articles NATurE IMMuNoLoGy of EAE and tracked CD45.2 + Ly6G-tdTomato + cells at days 1, 4 and 7 after transfer in the spleen and the CNS of host animals. Whereas transferred CD45.2 + Ly6G-tdTomato + cells disappeared from the peripheral immune compartment within two days, they accumulated and persisted in the CNS (Fig. 3d,e ). Donor CD45.2 + Ly6G-tdTomato + cells were positive for the proliferation marker Ki67 in the inflamed host CNS, but not in the spleen, and CNS-derived Ly6G-tdTomato + cells expressed high amounts of iNOS compared to Ly6G-tdTomato + cells re-isolated from the spleen (Fig. 3f ). These data indicate that Ly6G-tdTomato + cells converted into PMN-MDSCs and accumulated in the CNS compartment.
Ly6G + MDSCs prevent perpetuation of clinical signs of EAE.
Given the overlap in phenotype between human PMN-MDSCs and murine Ly6G-tdTomato + cells isolated from the CNS parenchyma, we tested whether the ablation or genetic loss of function of these cells in mice affected EAE progression. First, we depleted MDSCs in Ly6g Cre/WT mice with a monoclonal antibody to Ly6G starting at day 12, after onset of EAE. The depletion efficiency was around 90% in the blood and 80% in the CNS, as monitored by Ly6G-tdTomato expression ( Supplementary Fig. 3 ). In contrast to mice treated with control antibody, Ly6G-tdTomato + MDSC-depleted Ly6g Cre/WT mice did not recover from clinical signs of disease ( Fig. 4a ). Conversely, 
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expansion of Ly6G + cells by administration of granulocyte colonystimulating factor (G-CSF) as of day 12 led to faster and more complete recovery from clinical disease than in control-treated mice ( Fig. 4b ), suggesting that Ly6G + cells were suppressive by the time EAE peaked (after day 16). The numbers of CD11b + CD45 hi macrophages and CD4 + T cells as well as the fraction of IL-17-, IFN-γ -, GM-CSF-and IL-10producing CD4 + T cells and Foxp3 + T reg cells recovered from the CNS on day 21 were similar in control antibody-treated and Ly6G-tdTomato + MDSC-depleted Ly6g Cre/WT mice ( Supplementary Fig. 4 ). However, we detected a significantly greater (about three-fold) frequency and total number of CD19 + B cells in the spinal cord of Ly6G-tdTomato + MDSC-depleted Ly6g Cre/WT mice as compared to control antibody-treated mice ( Fig. 4c,e ), and a lower frequency and number of CD19 + B cells in the spinal cord of mice treated with G-CSF as compared with Ly6g Cre/WT mice treated with vehicle (5% glucose) ( Fig. 4d-f ). The frequencies of CD19 + B cells were inversely correlated with the frequencies of Ly6G + cells in the CNS parenchyma of G-CSF-treated and control-treated Ly6g Cre/WT mice at early disease recovery (day 21) ( Fig. 4g ). In addition, Ly6G-tdTomato + cells isolated from the CNS of Ly6g Cre/WT mice at early recovery (day 20) suppressed the proliferation of B cells stimulated with antibodies to CD40 and IL-4 after in vitro coculture. In contrast, Ly6G-tdTomato + cells isolated from the CNS of Ly6g Cre/WT mice at day 12 (EAE onset) and Ly6G-tdTomato + cells isolated from the spleen of Ly6g Cre/WT mice at all disease stages did not suppress the proliferation of B cells in cocultures ( Fig. 4h ). These data suggest that Ly6G-tdTomato + cells modulated inflammation during EAE by inhibiting the proliferation of B cells in the CNS.
STAT3 mediates Ly6G + cell conversion into MDSCs in the CNS.
Myeloid bone marrow precursors generate PMN-MDSCs after stimulation with GM-CSF and IL-6 in a manner dependent on the transcription factor CCAAT/enhancer-binding protein β (C/EBPβ ) 23 . Based on quantitative PCR analysis, Il6st-which encodes gp130, the signaling subunit of the IL-6 receptor complex-was among the top genes upregulated in CNS-derived Ly6G-tdTomato + cells as compared to splenic Ly6G-tdTomato + cells ( Fig. 5a ). RNA-seq analysis on Ly6G-tdTomato + cells indicated that STAT3-targeted genes 24 were highly enriched in CNS-onset Ly6G-tdTomato + cells compared to CNS-recovery and spleen Ly6G-tdTomato + cells (Fig. 5b) . To test whether STAT3-dependent signaling determined the functional phenotype of Ly6G-tdTomato + cells in the CNS, we generated mice with a conditional deletion of STAT3 in Ly6G + cells (Stat3 ΔLy6G hereafter) by crossing Ly6g Cre/WT with Stat3 flox/flox mice. Stat3 ΔLy6G mice developed more severe EAE and did not recover from EAE as of day 20 (Fig. 5c ), similarly to Ly6G-tdTomato + MDSC-depleted mice. Conditional deletion of gp130 in Ly6g Cre/WT mice recapitulated 
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the phenotype of Stat3 ΔLy6G mice ( Supplementary Fig. 5 ). However, deletion of Il6ra, the IL-6-binding α -subunit of the IL-6 receptor complex, in Ly6G + cells in Ly6g Cre/WT × Il6ra flox/flox mice did not lead to more severe EAE than in Ly6g Cre/WT control mice. These data suggest that the differentiation of PMN-MDSCs from Ly6G + precursors in the CNS depends on gp130 and STAT3. In addition to the prolonged clinical phenotype in Stat3 ΔLy6G mice, we observed a greater frequency of CD19 + B cells in the CNS of Stat3 ΔLy6G mice than in Ly6g Cre/WT control mice (Fig. 5d ). The number and phenotype of T cells as well as the number of monocytes in the CNS of Stat3 ΔLy6G mice were similar to those observed in Ly6g Cre/WT controls ( Supplementary Fig. 6 ), suggesting that the STAT3-dependent activation of Ly6G + MDSCs inhibited the accumulation of B cells but not other immune cells in the CNS during EAE. To address whether Ly6G + MDSCs inhibited recruitment or expansion of B cells in the CNS, we measured the concentration of CSF chemokines required for B cell recruitment to the CNS by cytometric bead array. The amount of CXCL1 and CXCL13 protein in the 
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CSF was higher in Stat3 ΔLy6G mice than in Ly6g Cre/WT control mice on day 24 ( Fig. 5e ), suggesting that greater recruitment might partially explain the higher levels of CD19 + B cells in the CNS of mice with STAT3-deficient Ly6G + cells. Ly6G + MDSCs suppress the proliferation of lymphocytes by a variety of mechanisms 25, 26 . Coculture of Ly6G-tdTomato + MDSCs isolated from the CNS of wild-type mice during EAE recovery (day 21) with naive B cells that were stimulated with antibodies to CD40 plus IL-4 significantly suppressed B cell proliferation, whereas Ly6G-tdTomato + cells isolated from the CNS of Stat3 ΔLy6G mice did not (Fig. 5f) . The inhibitory effect of wild-type Ly6G-tdTomato + cells was blocked by the NOS inhibitor l-NMMA and by neutralizing antibodies to the immune-checkpoint proteins VISTA and to PD-L1 (CD274) (Fig. 5f ). Ki67 staining ex vivo indicated greater Ki67 binding to B cells, but not to T cells isolated from the CNS of Stat3 ΔLy6G mice, as compared to that in their counterparts isolated from Ly6g Cre/WT control mice on day 21 (Fig. 5g) . B cells rarely infiltrate the CNS of wild-type mice in MOG(35-55)induced EAE (Fig. 5h ). However, in immune histochemical analysis, there was a marked increase in B cell numbers in Stat3 ΔLy6G mice with MOG(35-55)-induced EAE compared to Ly6g Cre/WT controls after the peak of disease (day 23) (Fig. 5i) . In addition to a few cells scattered in the parenchyma, the majority of CD19 + B220 + B cells in Stat3 ΔLy6G mice were clustered together in the meninges ( Fig. 5i and Supplementary Fig. 7 ). Together, these data suggest that Ly6G + MDSCs suppressed B cell recruitment and proliferation in the meningeal compartment in wild-type mice during EAE.
Ly6G + cells interact with B cells in the CNS. Next, we characterized B cells in the CNS in the presence or absence of Ly6G-tdTomato + cells. The B cells in the CNS of Stat3 ΔLy6G mice or in Ly6G-tdTomato + MDSC-depleted Ly6g Cre/WT mice with EAE were IgM + CD21 − CD35 − B cells. We observed 30% greater fractions of activated CD23 + B cells in these mice as compared to wild-type EAE mice ( Fig. 6a and Supplementary Fig. 7 ). There was no difference in the percentage of CD138 + plasma cells in either the spleen or the CNS of Stat3 ΔLy6G mice compared to that in Ly6g Cre/WT controls (Fig. 6b ). CD23 is an activation marker of B cells, and CD23 + B cells in the CNS coexpressed IL-6 and GM-CSF (Fig. 6c ). Neither CD1 + CD5 + B cells, which have regulatory properties 27, nor unconventional B1 cells, which are CD23 low (ref. 28) , contributed to the greater numbers of B cells in the CNS of Stat3 ΔLy6G mice or Ly6G-tdTomato + MDSCdepleted Ly6g Cre/WT mice ( Supplementary Fig. 7) . A larger fraction of B cells in the brain and spinal cord of Stat3 ΔLy6G mice than that in Ly6g Cre/WT control mice secreted GM-CSF, but not IL-10, on day 23 (Fig. 6d,e and Supplementary Fig. 7 ). This is consistent with a higher fraction of activated CD23 + IgM + B cells in Stat3 ΔLy6G mice as compared to Ly6g Cre/WT mice. Most Ly6G-tdTomato + cells in the CNS co-stained for phosphorylated STAT3 (pSTAT3) in immunohistochemical analyses (Fig. 6f) , indicating that this pathway was activated in Ly6G + cells in the inflamed CNS. Ly6G-tdTomato + cells in the CNS of Stat3 ΔLy6G mice did not express STAT3 (Fig. 6g) . Notably, Ly6G-tdTomato + cells were detected in close proximity to B220 + B cell aggregates in 
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the meninges and superficial CNS parenchyma in Stat3 ΔLy6G mice as compared to Ly6g Cre/WT mice, which essentially lacked meningeal B cell infiltrates (Fig. 6f,h) . This suggests a direct interaction between B cells and Ly6G + cells in the meningeal compartment. To test whether direct interaction between B cells and Ly6G + cells led to activation of STAT3 in Ly6G + cells, splenic Ly6G + cells from C57BL/6 mice immunized with MOG(35-55) plus CFA were isolated on day 8 and incubated with IL-6 or a complex composed of soluble IL-6 receptor α (IL-6Rα ) and IL-6 (IL-6-IL-6Rα hereafter), which signals into cells even though they lack membrane expression of IL-6Rα . STAT3 activation, as assessed by expression of pSTAT3, was higher in Ly6G + cells in response to IL-6-IL-6Rα than in response to equimolar amounts of IL-6 ( Fig. 6i) , consistent with the lower expression of IL-6Rα on the cell membrane of activated Ly6G + cells. Notably, when Ly6G + cells isolated from the spleen of MOG(35-55) plus CFA-immunized wild-type mice on day 8 were cocultured with MOG-specific B cell receptor transgenic CD19 + B cells isolated from the spleen of MOG-specific Ig heavy-chain knock-in mice (also referred to as TH mice) 29 that were activated to produce IL-6 in vitro by coculture with MOG-specific T cell receptor transgenic T cells 30 and MOG protein, we detected an increase in pSTAT3 only in Ly6G + cells in direct contact with the B cells, but 
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NATurE IMMuNoLoGy not in Ly6G + cells separated from the B cells in a transwell chamber (Fig. 6j ). The increase in pSTAT3 in Ly6G + cells was partly reversible by blockade of IL-6Rα with a neutralizing antibody to IL-6Rα ( Fig. 6j) . These data suggest that direct cell contact between Ly6G + cells and B cells was required to activate STAT3 in Ly6G + cells, and that such interactions in the CNS might drive the conversion of Ly6G + cells into MDSCs, which in turn controls the activation of B cells in the CNS.
B cells in CNS prevent recovery from EAE in Stat3 ΔLy6G mice.
To test whether the diminished capacity to recover from EAE of Stat3 ΔLy6G mice was due to the higher frequency of activated CD23 + IgM + B cells in the CNS of these mice compared to Ly6g Cre/WT mice, we depleted the B cells by intravenous (i.v.) administration of an antibody to CD20. Intravenous treatment with an antibody to CD20 every five days after EAE onset (day 12) led to significant depletion of B cells in the brain and spinal cord of Stat3 ΔLy6G mice to numbers below those observed in wild-type EAE mice (Fig. 7a ).
In addition, the percentage of GM-CSF + B cells in CD20 antibodytreated EAE Stat3 ΔLy6G mice was similar to that found in wild-type EAE mice (Fig. 7b ). Treatment with CD20 antibody led to a more severe disease course of MOG(35-55)-induced EAE in wild-type mice compared to control antibody-treated wild-type mice (Fig. 7c) , consistent with previous reports 31 . In contrast, administration of the CD20 antibodies ameliorated clinical disease severity in MOG(35-55)-induced EAE in Stat3 ΔLy6G mice as compared to control antibody-treated Stat3 ΔLy6G mice (Fig. 7d) , indicating that B cells are responsible for the more severe EAE and chronic disease phenotype in the Stat3 ΔLy6G mice. Activated microglia have been associated with chronic inflammation in the CNS. RNA-seq data from microglia isolated from a chronic EAE model, as well as from experimental models of amyotrophic lateral sclerosis and Alzheimer's disease, have been used to define a 'neurotoxic' microglia profile 32 . As such, we tested whether dysfunction or depletion of MDSCs in the CNS of Stat3 ΔLy6G mice or Ly6G-depleted mice affected the phenotype of microglia. Because the TREM2-APOE pathway is upregulated in 'neurotoxic' microglia 32 , we tested the expression of candidate genes of the TREM2-APOE pathway in microglia from Stat3 ΔLy6G mice and Ly6g Cre/WT control mice in late stages of EAE (day 22). As compared to Ly6g Cre/WT EAE mice, sorted microglia from Stat3 ΔLy6G EAE mice had significantly higher expression of Clec7a, Gpnmb, Trem2 and ApoE (Supplementary Fig. 8 ) and lower expression of markers of homeostatic microglia, including Tmem119, P2ry12 and Sall1, at late stages of EAE (day 22) ( Supplementary Fig. 8 ). Thus, dysfunctional Ly6G-tdTomato + cells in the CNS of Stat3 ΔLy6G mice promoted a neurotoxic microglia profile. Together, these data establish that enhanced GM-CSF responses in B cells in the absence of functional MDSCs in the CNS are associated with tissue-destructive microglia activation.
Discussion
Here we show that immunoregulatory PMN-MDSCs are found as LOX1 + MDSCs in the CSF of MS subjects and as Ly6G + MDSCs in the CNS of mice with EAE during the recovery stage. Our analyses indicate that Ly6G + neutrophils differentiate into MDSCs in the CNS of wild-type mice in a STAT3-dependent manner and in turn control the accumulation and activation of B cells in this compartment. Loss of MDSCs leads to activation of B cells in the CNS, which-in part by secretion of GM-CSF-contributes to the establishment of compartmentalized inflammation in the CNS. B cells might be inducing an MDSC phenotype in a subset of neutrophils in the CNS, establishing a negative feedback loop that prevents perpetuation of inflammation in the CNS.
Bona fide neutrophils are short-lived. Their half-life is in the range of 5-10 h in the systemic compartment, and they must be constantly replenished by the bone marrow 33 . Even though genetic tools for the study of neutrophils have been limited, the role of neutrophils in EAE has been addressed 34 and they are considered to exert a proinflammatory function either by activating endothelial cells at the blood-brain-barrier for the enhanced recruitment of inflammatory cells 35 , by inducing the maturation of antigen-presenting cells in the CNS 36 , or through direct tissue destruction 37 . However, because autoimmune attacks of the CNS in humans are rarely hyperacute, the proinflammatory role of neutrophils might be limited. Rather, myeloid cells of neutrophil origin that reside in parenchymal tissues for up to 6 days (ref. 38 ) may be more relevant to the disease course of CNS autoimmunity.
Analyses of immune cell population dynamics in the CSF and CNS parenchyma of mice during EAE revealed a persistent population of Ly6G + cells at the beginning of the recovery stage. Because CXCL1 was also upregulated in the CSF at this stage, it is probable that various chemokine cues attract Ly6G + precursors into the CSF space through the chemokine receptor CXCR2 expressed on Ly6G + cells 39 . Murine CXCL1 is the functional homolog of human chemokines CXCL1 and CXCL8, which are detected in the CSF of people with MS 40 , and CXCL1 has been described as a hallmark effector molecule of T H 17 cell-driven autoimmunity in the CNS during EAE 41 . Ly6G + cells recruited to the CSF space during EAE differentiated into MDSCs in a STAT3-dependent manner. Notably, 
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NATurE IMMuNoLoGy hyperactivation of STAT3 in LysM + cells, which also make up a subset of neutrophils, leads to expansion of MDSCs in the colon and protection from experimental colitis 42 . Although the differentiation of Ly6G + cells into MDSCs in the CNS required gp130 and STAT3, it remains to be determined which ligands are responsible for this process. IL-6 is important in expanding and activating MDSCs 43 , and we confirmed that steady-state neutrophils express IL-6Rα , the IL-6-binding subunit of IL-6R. However, once activated, neutrophils shed IL-6Rα and most CNS Ly6G + cells lack IL-6Rα expression in EAE, consistent with the lack of a clinical phenotype in Il6ra ΔLy6G mice. Nevertheless, because cells lacking IL-6Rα expression can still receive IL-6 signals through IL-6 trans-signaling or IL-6 trans-presentation 44 , the local differentiation of Ly6G + cells into MDSCs could occur through cells that have the potential to present IL-6 in trans. Because B220 + B cells were in close proximity to Ly6G + cells in the meningeal space of Stat3 ΔLy6G mice, it is intriguing to speculate that CD19-BV510 48, 49 ). Depletion of B cells in this model leads to a more severe disease 31 . Conversely, in EAE models in which B cells serve as antigen-presenting cells, as sources of inflammatory cytokines or as precursors of cells that secrete pathogenic antibodies, depletion of B cells ameliorates the severity of EAE 31, 50 . Our data suggest that MDSCs in the CNS prevent the accumulation of B cells in the meningeal space and CNS parenchyma. When released from MDSCmediated suppression, B cells accumulate in the CNS compartment even in MOG(35-55)-induced EAE, and through their secretion of inflammatory cytokines-in particular GM-CSF-promote immunopathology. GM-CSF production has been reported in the socalled innate responses activator (IRA) B cells, which are thought to be derived from peritoneal B1 cells in a MyD88-dependent manner upon TLR4 stimulation 28 . The GM-CSF + B cells in the CNS compartment of Stat3 ΔLy6G mice were CD43 + CD93 + , similar to the IRA B cells; however, they were CD23 + and produced IL-6, suggesting they were more probably derived from conventional B cells. We did not observe a greater fraction of plasma cells in the CNS of Stat3 ΔLy6G mice as compared to controls. Yet a potential impact of MDSCs on germinal center reactions in the CNS needs further investigation.
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